Overview

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.
Phase:
Phase 3
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Cilastatin
Imipenem
Minocycline
Tigecycline